A traditional Chinese medicine composition for treating lung adenocarcinoma and improving cancer-related fatigue and pharmaceutical application thereof
The traditional Chinese medicine composition prepared by water extraction or alcohol extraction of Astragalus membranaceus and other Chinese medicinal materials is used to treat lung adenocarcinoma and cancer-related fatigue. It adopts the method of "strengthening the body's resistance and consolidating its foundation, and combining attack and tonification" to overcome the shortcomings of existing treatment methods, achieve rapid and lasting relief of fatigue and anti-tumor effects, and has good safety.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DONGZHIMEN HOSPITAL OF BEIJING UNIV OF CHINESE MEDICINE
- Filing Date
- 2026-02-12
- Publication Date
- 2026-07-17
AI Technical Summary
Existing traditional Chinese medicine formulas for treating lung adenocarcinoma and cancer-related fatigue are insufficient in terms of targeting, efficacy and safety. They are difficult to effectively control tumor progression while relieving fatigue, and long-term use has side effects and dependence.
This medicine composition is prepared by water extraction or alcohol extraction of a combination of Chinese medicinal herbs such as Astragalus membranaceus, processed turtle shell, Scutellaria barbata, Prunus mume, Agrimonia pilosa, calcined oyster shell, woodlice, Curcuma zedoaria, and Gentiana macrophylla. It is used for oral administration and is based on the traditional Chinese medicine principle of "strengthening the body's resistance and consolidating its foundation, and combining attack and tonification". It is designed to target the pathogenesis of lung adenocarcinoma and cancer-related fatigue, and has the effects of strengthening the spleen and kidneys, resolving blood stasis and dissipating nodules, and regulating the heart and detoxifying.
It significantly relieves fatigue associated with lung adenocarcinoma, improves quality of life, reduces the toxic side effects of radiotherapy and chemotherapy, enhances treatment efficacy, and is non-addictive, making it suitable for long-term use.
Smart Images
Figure CN122398972A_ABST